Curated News
By: NewsRamp Editorial Staff
June 29, 2026

SS Innovations Soars with Record Q1 Revenue, Global Expansion

Discuss on Substack View History of this news story on GitHub
Original Source

TLDR

  • SS Innovations' 116.8% revenue surge and 194 SSi Mantra installations signal strong market adoption and competitive edge.
  • The SSi Mantra system achieved 11,719 procedures with 2,100 trained physicians, supported by regulatory approvals in four new countries.
  • World's longest-distance robotic cardiac telesurgery expands access to life-saving care, making tomorrow better for remote patients.
  • The SSi Mantra performed over 170 different procedure types, including 212 pediatric surgeries and 175 telesurgeries.

Impact - Why it Matters

This news matters because SS Innovations is revolutionizing surgical care by making robotic-assisted procedures accessible in emerging markets and enabling remote telesurgeries that can bridge geographical gaps. The company’s rapid growth and regulatory wins suggest that affordable surgical robotics could soon become more widespread, potentially lowering healthcare costs and improving patient outcomes worldwide. For investors, the strong revenue growth and expanding installed base signal a promising trajectory in the medtech sector.

Summary

SS Innovations International (NASDAQ: SSII) has reported a record-breaking first-quarter 2026 revenue of $11.1 million, marking a 116.8% increase year over year, driven by growing adoption of its SSi Mantra surgical robotic system. The installed base of SSi Mantra systems reached 194 across 11 countries, with nearly 9,750 cumulative robotic procedures completed. The company also secured regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines during the quarter, expanding its international market access. Notably, SS Innovations recently completed the world’s longest-distance robotic cardiac telesurgery in history, showcasing the capabilities of its remote surgery platform. The company continues to pursue regulatory clearance in both the United States and Europe while expanding its presence in emerging healthcare markets.

As of June 22, 2026, the cumulative number of multi-specialty procedures completed with the SSi Mantra system totaled 11,719, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the system, which has been used to perform over 170 different types of procedures. This rapid adoption underscores the platform's versatility and the company's commitment to advancing surgical robotics globally. The strong financial performance and operational milestones position SS Innovations as a key player in the surgical robotics industry, with a focus on democratizing access to advanced surgical care in underserved regions.

InvestorWire (IW), a specialized communications platform, is syndicating this news. IW is one of over 75 brands within the Dynamic Brand Portfolio at IBN that delivers comprehensive corporate communications solutions. For more information, visit the company’s website at www.SSInnovations.com or InvestorWire for the full press release.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Soars with Record Q1 Revenue, Global Expansion

blockchain registration record for this content.